Back to Trials
NCT07290205EARLY_PHASE1RecruitingAccepts Healthy Volunteers

Remimazolam NeuroImaging

Keith M Vogt

Start Date

3/27/2026

Completion Date

12/2/2027

Summary

This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task

Eligibility Criteria

Age Range: 18 years to 59 years

Inclusion Criteria: * Adults 18-59 years of age, who: * have none of the specific exclusion criteria * have a valid email address and valid phone number throughout the study * free from any non-MRI compatible implants Exclusion Criteria: * are pregnant or attempting to conceive * body mass index (BMI) \> 35 * significant memory impairment or hearing loss * sleep apnea * chronic pain or frequently taking pain medication (including tramadol) * chronic medical conditions requiring treatment (hypertension, diabetes, high cholesterol) * neurologic disease, including seizures and tremor * psychiatric diagnoses, including anxiety, depression, panic, or PTSD * a history of any of these medical conditions: abnormal heartbeats (cardiac conduction abnormality or arrhythmia), liver or kidney disease, or significant lung disease * severe claustrophobia or MRI intolerance * have metal implants or non-removable metal piercings * having a history of adverse reaction to midazolam (Versed), lorazepam (Ativan) or another benzodiazepine class medication * are allergic to dextran * daily alcohol or heavy alcohol use; history of alcohol abuse * current daily smoker * regular or recent marijuana use (including prescribed/medical marijuana) * illicit drug use, i.e., street drugs * regularly taking: antiepileptics, antidepressants, anti-psychotics, antihistamines, anti-anxiety medication, stimulants, or sleep-aids

Interventions

DRUG

Remimazolam

DEVICE

Peripheral Nerve Stimulation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

AnesthesiaPainRemimazolam

Locations

University of Pittsburgh

Pittsburgh, Pennsylvania 15213

United States